Rankings
▼
Calendar
CGEN
Compugen Ltd.
$202M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-10.7% YoY
Gross Profit
-$116,000
-5.1% margin
Operating Income
-$8M
-367.6% margin
Net Income
-$7M
-314.4% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+55.3%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$115M
Total Liabilities
$58M
Stockholders' Equity
$57M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$3M
-10.7%
Gross Profit
-$116,000
$457,000
-125.4%
Operating Income
-$8M
-$8M
+1.1%
Net Income
-$7M
-$7M
+1.2%
← FY 2025
All Quarters
Q2 2025 →
CGEN Q1 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena